Abstract
I introduce social feasibility constraints in a SIR epidemiological model: at any point in time, the ability of a social planner to impose mitigation measures is limited, but it is increasing in the proportion of infected individuals. When considering threshold policies with constant levels of mitigation for a time period, the overall fatality rate in the population is non-monotonic in the levels of mitigation: higher levels of mitigation can increase the overall fatality rate. Intuitively, strong mitigation at a point in time can undermine the social feasibility of future mitigation.
“When the economists talk the trade-off talk, lots of epidemiologists (and others) find it morally reprehensible when people are dying.”
Noah Feldman, Bloomberg, April 2 2020.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding required.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
There is no data.